TY - JOUR
T1 - Empirical antimicrobial therapy for traveler’s diarrhea
AU - Adachi, Javier A.
AU - Ostrosky-Zeichner, Luis
AU - DuPont, Herbert L.
AU - Ericsson, Charles D.
PY - 2000/10/1
Y1 - 2000/10/1
N2 - Over 7 million cases of traveler’s diarrhea, defined as the passage of ≥3 unformed stools in a 24-h period, occur each year among visitors to developing countries. Bacterial enteric pathogens are the most common etiologic agents isolated. Preliminary clinical results for patients with diarrhea predominately caused by Campylobacter species have shown that azithromycin may be an effective alternative to fluoroquinolones for the treatment of traveler’s diarrhea.
AB - Over 7 million cases of traveler’s diarrhea, defined as the passage of ≥3 unformed stools in a 24-h period, occur each year among visitors to developing countries. Bacterial enteric pathogens are the most common etiologic agents isolated. Preliminary clinical results for patients with diarrhea predominately caused by Campylobacter species have shown that azithromycin may be an effective alternative to fluoroquinolones for the treatment of traveler’s diarrhea.
UR - http://www.scopus.com/inward/record.url?scp=0034452464&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0034452464&partnerID=8YFLogxK
U2 - 10.1086/318119
DO - 10.1086/318119
M3 - Article
C2 - 11049792
AN - SCOPUS:0034452464
SN - 1058-4838
VL - 31
SP - 1079
EP - 1083
JO - Clinical Infectious Diseases
JF - Clinical Infectious Diseases
IS - 4
ER -